Table 1 Initial characteristics of the disease during hospitalisation of patients assessed at M6 and M12 (n = 120)
From: Fatigue and quality-of-life in the year following SARS-Cov2 infection
Variables | Number (%) | Median [IQR] |
|---|---|---|
Socio-demographic characteristics | ||
Age | 63.50 [54.00–71.25] | |
> 70 years old | 32 (26.67) | |
Men | 65 (54.17) | |
Live at home | 120 (100.00) | |
Symptoms | ||
Fever | 92 (76.67) | |
Cough | 88 (73.33) | |
Dyspnoea | 80 (66.67) | |
Headache | 19 (15.83) | |
Diarrhoea | 46 (38.30) | |
Anorexia | 20 (16.67) | |
Ageusia | 12 (10.00) | |
Anosmia | 17 (14.17) | |
Muscle pains | 34 (28.33) | |
Abdominal pains | 9 (7.50) | |
Clinical situation | ||
Severe clinical profilea | 42 (35.00) | |
Heart rate (beat/min) | 89.00 [80.00–99.75] | |
> 45 and ≤ 120 | 112 (94.92) | |
> 120 | 6 (5.08) | |
Respiratory rate (/min) | 21.50 [18.00–28.00] | |
> 30 | 20 (17.86) | |
Systolic blood pressure (mmHg) | 130.00 [120.0–143.5] | |
> 140 | 33 (28.45) | |
Glasgow score | 15.00 [15.00–15.00] | |
< 15 | 5 (4.67) | |
Early Warning Score | 6.00 [3.00–9.00] | |
≤ 4 | 44 (39.64) | |
> 4 and ≤ 6 | 18 (16.22) | |
> 6 | 49 (44.14) | |
Biology | ||
Creatinine (µmol/L) | 78.00 [61.50–94.50] | |
> 120 | 20 (16.81) | |
CRP (mg/L) | 92.00 [34.38–157.25] | |
< 40 | 33 (28.45) | |
≥ 40 and < 150 | 52 (44.83) | |
≥ 150 | 31 (26.72) | |
Lymphocytes (G/L) | 0.90 [0.60–1.20] | |
< 1.5 | 100 (84.03) | |
Neutrophils (G/L) | 5.10 [3.30–6.70] | |
< 2 | 4 (3.39) | |
Bacterial co-infection | 4 (3.33) | |
Therapeutics | ||
Antiviralsb | 107 (89.17) | |
Hydroxychloroquine | 26 (24.30) | |
Antibiotic therapy | 115 (95.83) | |
Corticoids | 80 (66.67) | |
Anticoagulants | 111 (92.50) | |
Evolution | ||
Transfer in ICU | 35 (29.17) | |
Oxygen therapy | 52 (43.33) | |
Pulmonary embolism | 9 (7.50) | |
Home visits | 88 (73.33) | |
Follow-up care and rehabilitation | 31 (26.67) | |
Re-hospitalisation | 5 (4.17) |